Epidemic response group to invest up to $384 mln
Post# of 714
(Total Views: 218)
Posted On: 05/11/2020 4:10:06 PM
Epidemic response group to invest up to $384 mln in Novavax's coronavirus vaccine
BY Reuters
— 4:04 PM ET 05/11/2020
May 11 (Reuters) - The Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $384 million to support the development and production of Novavax Inc's ( NVAX
Loading... Loading...
) vaccine candidate against the coronavirus, the company said on Monday.
CEPI, which was set up to fight emerging epidemics, said in March it will invest $4.4 million into deals with Novavax ( NVAX
Loading... Loading...
) and Britain's University of Oxford to develop potential vaccines against COVID-19.
CEPI has so far invested in the development of six vaccine candidates against COVID-19, including projects with the U.S. firms CureVac, Inovio Pharmaceuticals ( INO
Loading... Loading...
), Moderna ( MRNA
Loading... Loading...
), and with the University of Queensland in Australia. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur)
(2)
(0)Scroll down for more posts ▼